name,protein_id,protein_name,metabolite_name,metabolite_id,chemical_formula,smiles,average_moleclular_weight,taxonomy_direct_parent,taxonomy_class,taxonomy_sub_class
muscular dystrophy,15595,ACES_HUMAN,5-O-Desmethyldonepezil,HMDB0013958,C23H27NO3,COC1=C(O)C=C2CC(CC3CCN(CC4=CC=CC=C4)CC3)C(=O)C2=C1,365.4654,N-benzylpiperidines,Piperidines,Benzylpiperidines
muscular dystrophy,15595,ACES_HUMAN,5-O-Desmethyldonepezil,HMDB0013958,C23H27NO3,COC1=C(O)C=C2CC(CC3CCN(CC4=CC=CC=C4)CC3)C(=O)C2=C1,365.4654,N-benzylpiperidines,Piperidines,Benzylpiperidines
muscular dystrophy,15595,ACES_HUMAN,5-O-Desmethyldonepezil,HMDB0013958,C23H27NO3,COC1=C(O)C=C2CC(CC3CCN(CC4=CC=CC=C4)CC3)C(=O)C2=C1,365.4654,N-benzylpiperidines,Piperidines,Benzylpiperidines
muscular dystrophy,15595,ACES_HUMAN,Acetic acid,HMDB0000042,C2H4O2,CC(O)=O,60.052,Carboxylic acids,Carboxylic acids and derivatives,Carboxylic acids
muscular dystrophy,15595,ACES_HUMAN,Acetic acid,HMDB0000042,C2H4O2,CC(O)=O,60.052,Carboxylic acids,Carboxylic acids and derivatives,Carboxylic acids
muscular dystrophy,15595,ACES_HUMAN,Acetic acid,HMDB0000042,C2H4O2,CC(O)=O,60.052,Carboxylic acids,Carboxylic acids and derivatives,Carboxylic acids
muscular dystrophy,15595,ACES_HUMAN,Acetylcholine,HMDB0000895,C7H16NO2,CC(=O)OCC[N+](C)(C)C,146.2074,Acyl cholines,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,17341,CHLE_HUMAN,Acetylcholine,HMDB0000895,C7H16NO2,CC(=O)OCC[N+](C)(C)C,146.2074,Acyl cholines,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,15595,ACES_HUMAN,Acetylcholine,HMDB0000895,C7H16NO2,CC(=O)OCC[N+](C)(C)C,146.2074,Acyl cholines,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,15595,ACES_HUMAN,Acetylcholine,HMDB0000895,C7H16NO2,CC(=O)OCC[N+](C)(C)C,146.2074,Acyl cholines,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,17341,CHLE_HUMAN,Acetylcholine,HMDB0000895,C7H16NO2,CC(=O)OCC[N+](C)(C)C,146.2074,Acyl cholines,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,17341,CHLE_HUMAN,Acetylcholine,HMDB0000895,C7H16NO2,CC(=O)OCC[N+](C)(C)C,146.2074,Acyl cholines,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,16312,TRI32_HUMAN,Adenosine monophosphate,HMDB0000045,C10H14N5O7P,NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1,347.2212,Purine ribonucleoside monophosphates,Purine nucleotides,Purine ribonucleotides
muscular dystrophy,1273,DMPK_HUMAN,Adenosine triphosphate,HMDB0000538,C10H16N5O13P3,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,507.181,Purine ribonucleoside triphosphates,Purine nucleotides,Purine ribonucleotides
muscular dystrophy,16312,TRI32_HUMAN,Adenosine triphosphate,HMDB0000538,C10H16N5O13P3,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,507.181,Purine ribonucleoside triphosphates,Purine nucleotides,Purine ribonucleotides
muscular dystrophy,1273,DMPK_HUMAN,ADP,HMDB0001341,C10H15N5O10P2,NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O,427.2011,Purine ribonucleoside diphosphates,Purine nucleotides,Purine ribonucleotides
muscular dystrophy,15595,ACES_HUMAN,Ambenonium,HMDB0015254,C28H42Cl2N4O2,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC1=CC=CC=C1Cl,537.565,Alpha amino acid amides,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues"
muscular dystrophy,17341,CHLE_HUMAN,Ambenonium,HMDB0015254,C28H42Cl2N4O2,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC1=CC=CC=C1Cl,537.565,Alpha amino acid amides,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues"
muscular dystrophy,15595,ACES_HUMAN,Ambenonium,HMDB0015254,C28H42Cl2N4O2,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC1=CC=CC=C1Cl,537.565,Alpha amino acid amides,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues"
muscular dystrophy,17341,CHLE_HUMAN,Ambenonium,HMDB0015254,C28H42Cl2N4O2,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC1=CC=CC=C1Cl,537.565,Alpha amino acid amides,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues"
muscular dystrophy,15595,ACES_HUMAN,Ambenonium,HMDB0015254,C28H42Cl2N4O2,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC1=CC=CC=C1Cl,537.565,Alpha amino acid amides,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues"
muscular dystrophy,17341,CHLE_HUMAN,Ambenonium,HMDB0015254,C28H42Cl2N4O2,CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=CC=CC=C1Cl)CC1=CC=CC=C1Cl,537.565,Alpha amino acid amides,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues"
muscular dystrophy,17341,CHLE_HUMAN,Arachidic acid,HMDB0002212,C20H40O2,CCCCCCCCCCCCCCCCCCCC(O)=O,312.5304,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Arachidic acid,HMDB0002212,C20H40O2,CCCCCCCCCCCCCCCCCCCC(O)=O,312.5304,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Arachidic acid,HMDB0002212,C20H40O2,CCCCCCCCCCCCCCCCCCCC(O)=O,312.5304,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Arachidonic acid,HMDB0001043,C20H32O2,CCCCCC=C/CC=C/CC=C/CC=C/CCCC(O)=O,304.4669,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Arachidonic acid,HMDB0001043,C20H32O2,CCCCCC=C/CC=C/CC=C/CC=C/CCCC(O)=O,304.4669,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Arachidonic acid,HMDB0001043,C20H32O2,CCCCCC=C/CC=C/CC=C/CC=C/CCCC(O)=O,304.4669,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Bambuterol,HMDB0015478,C18H29N3O5,CN(C)C(=O)OC1=CC(=CC(OC(=O)N(C)C)=C1)C(O)CNC(C)(C)C,367.44,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,17341,CHLE_HUMAN,Bambuterol,HMDB0015478,C18H29N3O5,CN(C)C(=O)OC1=CC(=CC(OC(=O)N(C)C)=C1)C(O)CNC(C)(C)C,367.44,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,17341,CHLE_HUMAN,Bambuterol,HMDB0015478,C18H29N3O5,CN(C)C(=O)OC1=CC(=CC(OC(=O)N(C)C)=C1)C(O)CNC(C)(C)C,367.44,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,17341,CHLE_HUMAN,Butyric acid,HMDB0000039,C4H8O2,CCCC(O)=O,88.1051,Straight chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Butyric acid,HMDB0000039,C4H8O2,CCCC(O)=O,88.1051,Straight chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Butyric acid,HMDB0000039,C4H8O2,CCCC(O)=O,88.1051,Straight chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,19177,POMT1_HUMAN,Calcium,HMDB0000464,Ca,[Ca++],40.078,Homogeneous alkaline earth metal compounds,Homogeneous alkaline earth metal compounds,
muscular dystrophy,13034,CAN3_HUMAN,Calcium,HMDB0000464,Ca,[Ca++],40.078,Homogeneous alkaline earth metal compounds,Homogeneous alkaline earth metal compounds,
muscular dystrophy,15986,ANO5_HUMAN,Calcium,HMDB0000464,Ca,[Ca++],40.078,Homogeneous alkaline earth metal compounds,Homogeneous alkaline earth metal compounds,
muscular dystrophy,9963,POMT2_HUMAN,Calcium,HMDB0000464,Ca,[Ca++],40.078,Homogeneous alkaline earth metal compounds,Homogeneous alkaline earth metal compounds,
muscular dystrophy,15986,ANO5_HUMAN,Chloride ion,HMDB0000492,Cl,[Cl-],35.453,Homogeneous halogens,Homogeneous halogens,
muscular dystrophy,17341,CHLE_HUMAN,Chloroprocaine,HMDB0015292,C13H19ClN2O2,CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1,270.755,Benzoic acid esters,Benzene and substituted derivatives,Benzoic acids and derivatives
muscular dystrophy,17341,CHLE_HUMAN,Chloroprocaine,HMDB0015292,C13H19ClN2O2,CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1,270.755,Benzoic acid esters,Benzene and substituted derivatives,Benzoic acids and derivatives
muscular dystrophy,17341,CHLE_HUMAN,Chloroprocaine,HMDB0015292,C13H19ClN2O2,CCN(CC)CCOC(=O)C1=C(Cl)C=C(N)C=C1,270.755,Benzoic acid esters,Benzene and substituted derivatives,Benzoic acids and derivatives
muscular dystrophy,17341,CHLE_HUMAN,Chlorphenesin,HMDB0014994,C9H11ClO3,OCC(O)COC1=CC=C(Cl)C=C1,202.635,Phenol ethers,Phenol ethers,
muscular dystrophy,17341,CHLE_HUMAN,Chlorphenesin,HMDB0014994,C9H11ClO3,OCC(O)COC1=CC=C(Cl)C=C1,202.635,Phenol ethers,Phenol ethers,
muscular dystrophy,17341,CHLE_HUMAN,Chlorphenesin,HMDB0014994,C9H11ClO3,OCC(O)COC1=CC=C(Cl)C=C1,202.635,Phenol ethers,Phenol ethers,
muscular dystrophy,17341,CHLE_HUMAN,Chlorpromazine,HMDB0014620,C17H19ClN2S,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,318.864,Phenothiazines,Benzothiazines,Phenothiazines
muscular dystrophy,17341,CHLE_HUMAN,Chlorpromazine,HMDB0014620,C17H19ClN2S,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,318.864,Phenothiazines,Benzothiazines,Phenothiazines
muscular dystrophy,17341,CHLE_HUMAN,Chlorpromazine,HMDB0014620,C17H19ClN2S,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,318.864,Phenothiazines,Benzothiazines,Phenothiazines
muscular dystrophy,17341,CHLE_HUMAN,Choline,HMDB0000097,C5H14NO,C[N+](C)(C)CCO,104.1708,Cholines,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,15595,ACES_HUMAN,Choline,HMDB0000097,C5H14NO,C[N+](C)(C)CCO,104.1708,Cholines,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,15595,ACES_HUMAN,Choline,HMDB0000097,C5H14NO,C[N+](C)(C)CCO,104.1708,Cholines,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,17341,CHLE_HUMAN,Choline,HMDB0000097,C5H14NO,C[N+](C)(C)CCO,104.1708,Cholines,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,15595,ACES_HUMAN,Choline,HMDB0000097,C5H14NO,C[N+](C)(C)CCO,104.1708,Cholines,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,17341,CHLE_HUMAN,Choline,HMDB0000097,C5H14NO,C[N+](C)(C)CCO,104.1708,Cholines,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,17341,CHLE_HUMAN,Cisplatin,HMDB0014656,Cl2H4N2Pt,N[Pt](N)(Cl)Cl,298.035,Transition metal chlorides,Transition metal salts,Transition metal chlorides
muscular dystrophy,17341,CHLE_HUMAN,Cisplatin,HMDB0014656,Cl2H4N2Pt,N[Pt](N)(Cl)Cl,298.035,Transition metal chlorides,Transition metal salts,Transition metal chlorides
muscular dystrophy,17341,CHLE_HUMAN,Cisplatin,HMDB0014656,Cl2H4N2Pt,N[Pt](N)(Cl)Cl,298.035,Transition metal chlorides,Transition metal salts,Transition metal chlorides
muscular dystrophy,17341,CHLE_HUMAN,Cyclopentolate,HMDB0015114,C17H25NO3,CN(C)CCOC(=O)C(C1=CC=CC=C1)C1(O)CCCC1,291.3853,Benzene and substituted derivatives,Benzene and substituted derivatives,
muscular dystrophy,17341,CHLE_HUMAN,Cyclopentolate,HMDB0015114,C17H25NO3,CN(C)CCOC(=O)C(C1=CC=CC=C1)C1(O)CCCC1,291.3853,Benzene and substituted derivatives,Benzene and substituted derivatives,
muscular dystrophy,17341,CHLE_HUMAN,Cyclopentolate,HMDB0015114,C17H25NO3,CN(C)CCOC(=O)C(C1=CC=CC=C1)C1(O)CCCC1,291.3853,Benzene and substituted derivatives,Benzene and substituted derivatives,
muscular dystrophy,8327,SELN_HUMAN,Cysteinyl,HMDB0250708,C3H6NOS,NC(CS)[C]=O,104.15,Alkylthiols,Thiols,Alkylthiols
muscular dystrophy,8327,SELN_HUMAN,Cysteinyl,HMDB0250708,C3H6NOS,NC(CS)[C]=O,104.15,Alkylthiols,Thiols,Alkylthiols
muscular dystrophy,8327,SELN_HUMAN,Cysteinyl,HMDB0250708,C3H6NOS,NC(CS)[C]=O,104.15,Alkylthiols,Thiols,Alkylthiols
muscular dystrophy,17341,CHLE_HUMAN,D-Mannose,HMDB0000169,C6H12O6,OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O,180.1559,Hexoses,Organooxygen compounds,Carbohydrates and carbohydrate conjugates
muscular dystrophy,17341,CHLE_HUMAN,D-Mannose,HMDB0000169,C6H12O6,OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O,180.1559,Hexoses,Organooxygen compounds,Carbohydrates and carbohydrate conjugates
muscular dystrophy,17341,CHLE_HUMAN,D-Mannose,HMDB0000169,C6H12O6,OC[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O,180.1559,Hexoses,Organooxygen compounds,Carbohydrates and carbohydrate conjugates
muscular dystrophy,17836,GMPPB_HUMAN,D-Mannose 1-phosphate,HMDB0006330,C6H13O9P,OC[C@H]1O[C@H](OP(O)(O)=O)[C@@H](O)[C@@H](O)[C@@H]1O,260.1358,Monosaccharide phosphates,Organooxygen compounds,Carbohydrates and carbohydrate conjugates
muscular dystrophy,17341,CHLE_HUMAN,Decamethonium,HMDB0015375,C16H38N2,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,258.4863,Decamethonium compounds,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,15595,ACES_HUMAN,Decamethonium,HMDB0015375,C16H38N2,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,258.4863,Decamethonium compounds,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,15595,ACES_HUMAN,Decamethonium,HMDB0015375,C16H38N2,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,258.4863,Decamethonium compounds,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,17341,CHLE_HUMAN,Decamethonium,HMDB0015375,C16H38N2,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,258.4863,Decamethonium compounds,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,15595,ACES_HUMAN,Decamethonium,HMDB0015375,C16H38N2,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,258.4863,Decamethonium compounds,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,17341,CHLE_HUMAN,Decamethonium,HMDB0015375,C16H38N2,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C,258.4863,Decamethonium compounds,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,17341,CHLE_HUMAN,Demecarium,HMDB0015079,C32H52N4O4,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C,556.7797,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,15595,ACES_HUMAN,Demecarium,HMDB0015079,C32H52N4O4,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C,556.7797,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,17341,CHLE_HUMAN,Demecarium,HMDB0015079,C32H52N4O4,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C,556.7797,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,15595,ACES_HUMAN,Demecarium,HMDB0015079,C32H52N4O4,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C,556.7797,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,15595,ACES_HUMAN,Demecarium,HMDB0015079,C32H52N4O4,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C,556.7797,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,17341,CHLE_HUMAN,Demecarium,HMDB0015079,C32H52N4O4,CN(CCCCCCCCCCN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C,556.7797,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,17341,CHLE_HUMAN,Dibucaine,HMDB0014668,C20H29N3O2,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,343.4632,Quinolones and derivatives,Quinolines and derivatives,Quinolones and derivatives
muscular dystrophy,17341,CHLE_HUMAN,Dibucaine,HMDB0014668,C20H29N3O2,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,343.4632,Quinolones and derivatives,Quinolines and derivatives,Quinolones and derivatives
muscular dystrophy,17341,CHLE_HUMAN,Dibucaine,HMDB0014668,C20H29N3O2,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,343.4632,Quinolones and derivatives,Quinolines and derivatives,Quinolones and derivatives
muscular dystrophy,17341,CHLE_HUMAN,Diethylcarbamazine,HMDB0014849,C10H21N3O,CCN(CC)C(=O)N1CCN(C)CC1,199.2932,Piperazine carboxamides,Diazinanes,Piperazines
muscular dystrophy,17341,CHLE_HUMAN,Diethylcarbamazine,HMDB0014849,C10H21N3O,CCN(CC)C(=O)N1CCN(C)CC1,199.2932,Piperazine carboxamides,Diazinanes,Piperazines
muscular dystrophy,17341,CHLE_HUMAN,Diethylcarbamazine,HMDB0014849,C10H21N3O,CCN(CC)C(=O)N1CCN(C)CC1,199.2932,Piperazine carboxamides,Diazinanes,Piperazines
muscular dystrophy,17341,CHLE_HUMAN,Dipivefrin,HMDB0014592,C19H29NO5,CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1,351.4373,Phenol esters,Phenol esters,
muscular dystrophy,17341,CHLE_HUMAN,Dipivefrin,HMDB0014592,C19H29NO5,CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1,351.4373,Phenol esters,Phenol esters,
muscular dystrophy,17341,CHLE_HUMAN,Dipivefrin,HMDB0014592,C19H29NO5,CNCC(O)C1=CC(OC(=O)C(C)(C)C)=C(OC(=O)C(C)(C)C)C=C1,351.4373,Phenol esters,Phenol esters,
muscular dystrophy,19177,POMT1_HUMAN,Dolichol phosphate,HMDB0006353,(C5H8)nC10H21O4P,CC(CCOP(O)(O)=O)CCC=C(/C)CCC=C(C)C,,Sesquiterpenoids,Prenol lipids,Sesquiterpenoids
muscular dystrophy,9963,POMT2_HUMAN,Dolichol phosphate,HMDB0006353,(C5H8)nC10H21O4P,CC(CCOP(O)(O)=O)CCC=C(/C)CCC=C(C)C,,Sesquiterpenoids,Prenol lipids,Sesquiterpenoids
muscular dystrophy,224,DPM1_HUMAN,Dolichol phosphate,HMDB0006353,(C5H8)nC10H21O4P,CC(CCOP(O)(O)=O)CCC=C(/C)CCC=C(C)C,,Sesquiterpenoids,Prenol lipids,Sesquiterpenoids
muscular dystrophy,225,DPM2_HUMAN,Dolichol-20,HMDB0005176,C100H164O,CC(CCO)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(C)C,1382.3716,Polyprenols,Prenol lipids,Polyprenols
muscular dystrophy,19177,POMT1_HUMAN,Dolichol-20,HMDB0005176,C100H164O,CC(CCO)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(C)C,1382.3716,Polyprenols,Prenol lipids,Polyprenols
muscular dystrophy,226,DPM3_HUMAN,Dolichol-20,HMDB0005176,C100H164O,CC(CCO)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(C)C,1382.3716,Polyprenols,Prenol lipids,Polyprenols
muscular dystrophy,224,DPM1_HUMAN,Dolichol-20,HMDB0005176,C100H164O,CC(CCO)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(C)C,1382.3716,Polyprenols,Prenol lipids,Polyprenols
muscular dystrophy,9963,POMT2_HUMAN,Dolichol-20,HMDB0005176,C100H164O,CC(CCO)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(C)C,1382.3716,Polyprenols,Prenol lipids,Polyprenols
muscular dystrophy,224,DPM1_HUMAN,Dolichyl beta-D-mannosyl phosphate,HMDB0012218,C86H143O9P,OC[C@H]1O[C@@H](OP(=O)(O)OCCC(C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(/C)CCC=C(C)C)[C@@H](O)[C@@H](O)[C@@H]1O,1352.024,Dolichyl monophosphates,Prenol lipids,Polyprenols
muscular dystrophy,19177,POMT1_HUMAN,Dolichyl phosphate D-mannose,HMDB0000994,C6H13O9P,OC[C@H]1O[C@@H](OP(O)(O)=O)[C@@H](O)[C@@H](O)[C@@H]1O,260.1358,Monosaccharide phosphates,Organooxygen compounds,Carbohydrates and carbohydrate conjugates
muscular dystrophy,226,DPM3_HUMAN,Dolichyl phosphate D-mannose,HMDB0000994,C6H13O9P,OC[C@H]1O[C@@H](OP(O)(O)=O)[C@@H](O)[C@@H](O)[C@@H]1O,260.1358,Monosaccharide phosphates,Organooxygen compounds,Carbohydrates and carbohydrate conjugates
muscular dystrophy,9963,POMT2_HUMAN,Dolichyl phosphate D-mannose,HMDB0000994,C6H13O9P,OC[C@H]1O[C@@H](OP(O)(O)=O)[C@@H](O)[C@@H](O)[C@@H]1O,260.1358,Monosaccharide phosphates,Organooxygen compounds,Carbohydrates and carbohydrate conjugates
muscular dystrophy,224,DPM1_HUMAN,Dolichyl phosphate D-mannose,HMDB0000994,C6H13O9P,OC[C@H]1O[C@@H](OP(O)(O)=O)[C@@H](O)[C@@H](O)[C@@H]1O,260.1358,Monosaccharide phosphates,Organooxygen compounds,Carbohydrates and carbohydrate conjugates
muscular dystrophy,225,DPM2_HUMAN,Dolichyl phosphate D-mannose,HMDB0000994,C6H13O9P,OC[C@H]1O[C@@H](OP(O)(O)=O)[C@@H](O)[C@@H](O)[C@@H]1O,260.1358,Monosaccharide phosphates,Organooxygen compounds,Carbohydrates and carbohydrate conjugates
muscular dystrophy,15595,ACES_HUMAN,Donepezil,HMDB0005041,C24H29NO3,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,379.492,N-benzylpiperidines,Piperidines,Benzylpiperidines
muscular dystrophy,15595,ACES_HUMAN,Donepezil,HMDB0005041,C24H29NO3,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,379.492,N-benzylpiperidines,Piperidines,Benzylpiperidines
muscular dystrophy,17341,CHLE_HUMAN,Donepezil,HMDB0005041,C24H29NO3,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,379.492,N-benzylpiperidines,Piperidines,Benzylpiperidines
muscular dystrophy,17341,CHLE_HUMAN,Donepezil,HMDB0005041,C24H29NO3,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,379.492,N-benzylpiperidines,Piperidines,Benzylpiperidines
muscular dystrophy,15595,ACES_HUMAN,Donepezil,HMDB0005041,C24H29NO3,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,379.492,N-benzylpiperidines,Piperidines,Benzylpiperidines
muscular dystrophy,17341,CHLE_HUMAN,Donepezil,HMDB0005041,C24H29NO3,COC1=C(OC)C=C2C(=O)C(CC3CCN(CC4=CC=CC=C4)CC3)CC2=C1,379.492,N-benzylpiperidines,Piperidines,Benzylpiperidines
muscular dystrophy,17341,CHLE_HUMAN,Doxacurium chloride,HMDB0015266,C56H78N2O16,COC1=CC(CC2C3=C(CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCC4=C(C2CC2=CC(OC)=C(OC)C(OC)=C2)C(OC)=C(OC)C(OC)=C4)C=C(OC)C(OC)=C3OC)=CC(OC)=C1OC,1035.2223,Benzylisoquinolines,Isoquinolines and derivatives,Benzylisoquinolines
muscular dystrophy,17341,CHLE_HUMAN,Doxacurium chloride,HMDB0015266,C56H78N2O16,COC1=CC(CC2C3=C(CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCC4=C(C2CC2=CC(OC)=C(OC)C(OC)=C2)C(OC)=C(OC)C(OC)=C4)C=C(OC)C(OC)=C3OC)=CC(OC)=C1OC,1035.2223,Benzylisoquinolines,Isoquinolines and derivatives,Benzylisoquinolines
muscular dystrophy,17341,CHLE_HUMAN,Doxacurium chloride,HMDB0015266,C56H78N2O16,COC1=CC(CC2C3=C(CC[N+]2(C)CCCOC(=O)CCC(=O)OCCC[N+]2(C)CCC4=C(C2CC2=CC(OC)=C(OC)C(OC)=C2)C(OC)=C(OC)C(OC)=C4)C=C(OC)C(OC)=C3OC)=CC(OC)=C1OC,1035.2223,Benzylisoquinolines,Isoquinolines and derivatives,Benzylisoquinolines
muscular dystrophy,17341,CHLE_HUMAN,Drospirenone,HMDB0015467,C24H30O3,[H][C@@]12C[C@]1([H])[C@@]1([H])[C@]3([H])[C@]4([H])C[C@]4([H])[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@]1([H])[C@@]1(C)CCC(=O)C=C21,366.4932,Spironolactones and derivatives,Steroids and steroid derivatives,Steroid lactones
muscular dystrophy,17341,CHLE_HUMAN,Drospirenone,HMDB0015467,C24H30O3,[H][C@@]12C[C@]1([H])[C@@]1([H])[C@]3([H])[C@]4([H])C[C@]4([H])[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@]1([H])[C@@]1(C)CCC(=O)C=C21,366.4932,Spironolactones and derivatives,Steroids and steroid derivatives,Steroid lactones
muscular dystrophy,17341,CHLE_HUMAN,Drospirenone,HMDB0015467,C24H30O3,[H][C@@]12C[C@]1([H])[C@@]1([H])[C@]3([H])[C@]4([H])C[C@]4([H])[C@@]4(CCC(=O)O4)[C@@]3(C)CC[C@]1([H])[C@@]1(C)CCC(=O)C=C21,366.4932,Spironolactones and derivatives,Steroids and steroid derivatives,Steroid lactones
muscular dystrophy,17341,CHLE_HUMAN,Echothiophate,HMDB0015190,C9H23NO3PS,CCOP(=O)(OCC)SCC[N+](C)(C)C,256.323,Tetraalkylammonium salts,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,17341,CHLE_HUMAN,Echothiophate,HMDB0015190,C9H23NO3PS,CCOP(=O)(OCC)SCC[N+](C)(C)C,256.323,Tetraalkylammonium salts,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,17341,CHLE_HUMAN,Echothiophate,HMDB0015190,C9H23NO3PS,CCOP(=O)(OCC)SCC[N+](C)(C)C,256.323,Tetraalkylammonium salts,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,17341,CHLE_HUMAN,Edrophonium,HMDB0015145,C10H16NO,CC[N+](C)(C)C1=CC(O)=CC=C1,166.2401,Aniline and substituted anilines,Benzene and substituted derivatives,Aniline and substituted anilines
muscular dystrophy,15595,ACES_HUMAN,Edrophonium,HMDB0015145,C10H16NO,CC[N+](C)(C)C1=CC(O)=CC=C1,166.2401,Aniline and substituted anilines,Benzene and substituted derivatives,Aniline and substituted anilines
muscular dystrophy,15595,ACES_HUMAN,Edrophonium,HMDB0015145,C10H16NO,CC[N+](C)(C)C1=CC(O)=CC=C1,166.2401,Aniline and substituted anilines,Benzene and substituted derivatives,Aniline and substituted anilines
muscular dystrophy,17341,CHLE_HUMAN,Edrophonium,HMDB0015145,C10H16NO,CC[N+](C)(C)C1=CC(O)=CC=C1,166.2401,Aniline and substituted anilines,Benzene and substituted derivatives,Aniline and substituted anilines
muscular dystrophy,17341,CHLE_HUMAN,Edrophonium,HMDB0015145,C10H16NO,CC[N+](C)(C)C1=CC(O)=CC=C1,166.2401,Aniline and substituted anilines,Benzene and substituted derivatives,Aniline and substituted anilines
muscular dystrophy,15595,ACES_HUMAN,Edrophonium,HMDB0015145,C10H16NO,CC[N+](C)(C)C1=CC(O)=CC=C1,166.2401,Aniline and substituted anilines,Benzene and substituted derivatives,Aniline and substituted anilines
muscular dystrophy,16524,TMM43_HUMAN,Emerin,HMDB0251772,C20H16N2O2,COC1=CC=C(C=C(C#N)C(=CC2=CC=C(OC)C=C2)C#N)C=C1,316.36,"Lignans, neolignans and related compounds",,
muscular dystrophy,17341,CHLE_HUMAN,Ephedrine,HMDB0015451,C10H15NO,CN[C@@H](C)[C@H](O)C1=CC=CC=C1,165.2322,Phenylpropanes,Benzene and substituted derivatives,Phenylpropanes
muscular dystrophy,15595,ACES_HUMAN,Ephedrine,HMDB0015451,C10H15NO,CN[C@@H](C)[C@H](O)C1=CC=CC=C1,165.2322,Phenylpropanes,Benzene and substituted derivatives,Phenylpropanes
muscular dystrophy,17341,CHLE_HUMAN,Ephedrine,HMDB0015451,C10H15NO,CN[C@@H](C)[C@H](O)C1=CC=CC=C1,165.2322,Phenylpropanes,Benzene and substituted derivatives,Phenylpropanes
muscular dystrophy,15595,ACES_HUMAN,Ephedrine,HMDB0015451,C10H15NO,CN[C@@H](C)[C@H](O)C1=CC=CC=C1,165.2322,Phenylpropanes,Benzene and substituted derivatives,Phenylpropanes
muscular dystrophy,17341,CHLE_HUMAN,Ephedrine,HMDB0015451,C10H15NO,CN[C@@H](C)[C@H](O)C1=CC=CC=C1,165.2322,Phenylpropanes,Benzene and substituted derivatives,Phenylpropanes
muscular dystrophy,15595,ACES_HUMAN,Ephedrine,HMDB0015451,C10H15NO,CN[C@@H](C)[C@H](O)C1=CC=CC=C1,165.2322,Phenylpropanes,Benzene and substituted derivatives,Phenylpropanes
muscular dystrophy,17341,CHLE_HUMAN,Ethopropazine,HMDB0014536,C19H24N2S,CCN(CC)C(C)CN1C2=CC=CC=C2SC2=CC=CC=C12,312.472,Phenothiazines,Benzothiazines,Phenothiazines
muscular dystrophy,17341,CHLE_HUMAN,Ethopropazine,HMDB0014536,C19H24N2S,CCN(CC)C(C)CN1C2=CC=CC=C2SC2=CC=CC=C12,312.472,Phenothiazines,Benzothiazines,Phenothiazines
muscular dystrophy,17341,CHLE_HUMAN,Ethopropazine,HMDB0014536,C19H24N2S,CCN(CC)C(C)CN1C2=CC=CC=C2SC2=CC=CC=C12,312.472,Phenothiazines,Benzothiazines,Phenothiazines
muscular dystrophy,15595,ACES_HUMAN,Galantamine,HMDB0014812,C17H21NO3,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,287.3535,Galanthamine-type amaryllidaceae alkaloids,Amaryllidaceae alkaloids,Galanthamine-type amaryllidaceae alkaloids
muscular dystrophy,17341,CHLE_HUMAN,Galantamine,HMDB0014812,C17H21NO3,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,287.3535,Galanthamine-type amaryllidaceae alkaloids,Amaryllidaceae alkaloids,Galanthamine-type amaryllidaceae alkaloids
muscular dystrophy,15595,ACES_HUMAN,Galantamine,HMDB0014812,C17H21NO3,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,287.3535,Galanthamine-type amaryllidaceae alkaloids,Amaryllidaceae alkaloids,Galanthamine-type amaryllidaceae alkaloids
muscular dystrophy,15595,ACES_HUMAN,Galantamine,HMDB0014812,C17H21NO3,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,287.3535,Galanthamine-type amaryllidaceae alkaloids,Amaryllidaceae alkaloids,Galanthamine-type amaryllidaceae alkaloids
muscular dystrophy,17341,CHLE_HUMAN,Galantamine,HMDB0014812,C17H21NO3,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,287.3535,Galanthamine-type amaryllidaceae alkaloids,Amaryllidaceae alkaloids,Galanthamine-type amaryllidaceae alkaloids
muscular dystrophy,17341,CHLE_HUMAN,Galantamine,HMDB0014812,C17H21NO3,[H][C@]12C[C@@H](O)C=C[C@]11CCN(C)CC3=C1C(O2)=C(OC)C=C3,287.3535,Galanthamine-type amaryllidaceae alkaloids,Amaryllidaceae alkaloids,Galanthamine-type amaryllidaceae alkaloids
muscular dystrophy,15595,ACES_HUMAN,Gallamine Triethiodide,HMDB0014626,C30H60N3O3,CC[N+](CC)(CC)CCOC1=CC=CC(OCC[N+](CC)(CC)CC)=C1OCC[N+](CC)(CC)CC,510.8157,Phenol ethers,Phenol ethers,
muscular dystrophy,15595,ACES_HUMAN,Gallamine Triethiodide,HMDB0014626,C30H60N3O3,CC[N+](CC)(CC)CCOC1=CC=CC(OCC[N+](CC)(CC)CC)=C1OCC[N+](CC)(CC)CC,510.8157,Phenol ethers,Phenol ethers,
muscular dystrophy,15595,ACES_HUMAN,Gallamine Triethiodide,HMDB0014626,C30H60N3O3,CC[N+](CC)(CC)CCOC1=CC=CC(OCC[N+](CC)(CC)CC)=C1OCC[N+](CC)(CC)CC,510.8157,Phenol ethers,Phenol ethers,
muscular dystrophy,225,DPM2_HUMAN,Guanosine diphosphate,HMDB0001201,C10H15N5O11P2,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,443.2005,Purine ribonucleoside diphosphates,Purine nucleotides,Purine ribonucleotides
muscular dystrophy,224,DPM1_HUMAN,Guanosine diphosphate,HMDB0001201,C10H15N5O11P2,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,443.2005,Purine ribonucleoside diphosphates,Purine nucleotides,Purine ribonucleotides
muscular dystrophy,226,DPM3_HUMAN,Guanosine diphosphate,HMDB0001201,C10H15N5O11P2,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,443.2005,Purine ribonucleoside diphosphates,Purine nucleotides,Purine ribonucleotides
muscular dystrophy,17836,GMPPB_HUMAN,Guanosine diphosphate,HMDB0001201,C10H15N5O11P2,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,443.2005,Purine ribonucleoside diphosphates,Purine nucleotides,Purine ribonucleotides
muscular dystrophy,224,DPM1_HUMAN,Guanosine diphosphate mannose,HMDB0001163,C16H25N5O16P2,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)C(=O)N1,605.3411,Purine nucleotide sugars,Purine nucleotides,Purine nucleotide sugars
muscular dystrophy,225,DPM2_HUMAN,Guanosine diphosphate mannose,HMDB0001163,C16H25N5O16P2,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)C(=O)N1,605.3411,Purine nucleotide sugars,Purine nucleotides,Purine nucleotide sugars
muscular dystrophy,226,DPM3_HUMAN,Guanosine diphosphate mannose,HMDB0001163,C16H25N5O16P2,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)C(=O)N1,605.3411,Purine nucleotide sugars,Purine nucleotides,Purine nucleotide sugars
muscular dystrophy,17836,GMPPB_HUMAN,Guanosine diphosphate mannose,HMDB0001163,C16H25N5O16P2,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)C(=O)N1,605.3411,Purine nucleotide sugars,Purine nucleotides,Purine nucleotide sugars
muscular dystrophy,17836,GMPPB_HUMAN,Guanosine triphosphate,HMDB0001273,C10H16N5O14P3,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,523.1804,Purine ribonucleoside triphosphates,Purine nucleotides,Purine ribonucleotides
muscular dystrophy,18683,PABP2_HUMAN,Guanosine triphosphate,HMDB0001273,C10H16N5O14P3,NC1=NC2=C(N=CN2[C@@H]2O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]2O)C(=O)N1,523.1804,Purine ribonucleoside triphosphates,Purine nucleotides,Purine ribonucleotides
muscular dystrophy,17341,CHLE_HUMAN,Heptadecanoic acid,HMDB0002259,C17H34O2,CCCCCCCCCCCCCCCCC(O)=O,270.4507,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Heptadecanoic acid,HMDB0002259,C17H34O2,CCCCCCCCCCCCCCCCC(O)=O,270.4507,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Heptadecanoic acid,HMDB0002259,C17H34O2,CCCCCCCCCCCCCCCCC(O)=O,270.4507,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Heptadecanoyl CoA,HMDB0006497,C38H68N7O17P3S,CCCCCCCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C(N)N=CN=C12,1019.97,Long-chain fatty acyl CoAs,Fatty Acyls,Fatty acyl thioesters
muscular dystrophy,17341,CHLE_HUMAN,Heptadecanoyl CoA,HMDB0006497,C38H68N7O17P3S,CCCCCCCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C(N)N=CN=C12,1019.97,Long-chain fatty acyl CoAs,Fatty Acyls,Fatty acyl thioesters
muscular dystrophy,17341,CHLE_HUMAN,Heptadecanoyl CoA,HMDB0006497,C38H68N7O17P3S,CCCCCCCCCCCCCCCCC(=O)SCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP(O)(O)=O)N1C=NC2=C(N)N=CN=C12,1019.97,Long-chain fatty acyl CoAs,Fatty Acyls,Fatty acyl thioesters
muscular dystrophy,15595,ACES_HUMAN,Isoflurophate,HMDB0014815,C6H14FO3P,CC(C)OP(F)(=O)OC(C)C,184.1457,Phosphate esters,Organic phosphoric acids and derivatives,Phosphate esters
muscular dystrophy,17341,CHLE_HUMAN,Isoflurophate,HMDB0014815,C6H14FO3P,CC(C)OP(F)(=O)OC(C)C,184.1457,Phosphate esters,Organic phosphoric acids and derivatives,Phosphate esters
muscular dystrophy,17341,CHLE_HUMAN,Isoflurophate,HMDB0014815,C6H14FO3P,CC(C)OP(F)(=O)OC(C)C,184.1457,Phosphate esters,Organic phosphoric acids and derivatives,Phosphate esters
muscular dystrophy,15595,ACES_HUMAN,Isoflurophate,HMDB0014815,C6H14FO3P,CC(C)OP(F)(=O)OC(C)C,184.1457,Phosphate esters,Organic phosphoric acids and derivatives,Phosphate esters
muscular dystrophy,17341,CHLE_HUMAN,Isoflurophate,HMDB0014815,C6H14FO3P,CC(C)OP(F)(=O)OC(C)C,184.1457,Phosphate esters,Organic phosphoric acids and derivatives,Phosphate esters
muscular dystrophy,15595,ACES_HUMAN,Isoflurophate,HMDB0014815,C6H14FO3P,CC(C)OP(F)(=O)OC(C)C,184.1457,Phosphate esters,Organic phosphoric acids and derivatives,Phosphate esters
muscular dystrophy,15595,ACES_HUMAN,L-Fucose,HMDB0000174,C6H12O5,C[C@@H]1O[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O,164.1565,Hexoses,Organooxygen compounds,Carbohydrates and carbohydrate conjugates
muscular dystrophy,15595,ACES_HUMAN,L-Fucose,HMDB0000174,C6H12O5,C[C@@H]1O[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O,164.1565,Hexoses,Organooxygen compounds,Carbohydrates and carbohydrate conjugates
muscular dystrophy,15595,ACES_HUMAN,L-Fucose,HMDB0000174,C6H12O5,C[C@@H]1O[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O,164.1565,Hexoses,Organooxygen compounds,Carbohydrates and carbohydrate conjugates
muscular dystrophy,19177,POMT1_HUMAN,Magnesium,HMDB0000547,Mg,[Mg++],24.305,Homogeneous alkaline earth metal compounds,Homogeneous alkaline earth metal compounds,
muscular dystrophy,7626,TITIN_HUMAN,Magnesium,HMDB0000547,Mg,[Mg++],24.305,Homogeneous alkaline earth metal compounds,Homogeneous alkaline earth metal compounds,
muscular dystrophy,9963,POMT2_HUMAN,Magnesium,HMDB0000547,Mg,[Mg++],24.305,Homogeneous alkaline earth metal compounds,Homogeneous alkaline earth metal compounds,
muscular dystrophy,1273,DMPK_HUMAN,Magnesium,HMDB0000547,Mg,[Mg++],24.305,Homogeneous alkaline earth metal compounds,Homogeneous alkaline earth metal compounds,
muscular dystrophy,17341,CHLE_HUMAN,Malathion,HMDB0014910,C10H19O6PS2,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,330.358,Fatty acid esters,Fatty Acyls,Fatty acid esters
muscular dystrophy,17341,CHLE_HUMAN,Malathion,HMDB0014910,C10H19O6PS2,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,330.358,Fatty acid esters,Fatty Acyls,Fatty acid esters
muscular dystrophy,17341,CHLE_HUMAN,Malathion,HMDB0014910,C10H19O6PS2,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,330.358,Fatty acid esters,Fatty Acyls,Fatty acid esters
muscular dystrophy,19177,POMT1_HUMAN,Manganese,HMDB0001333,Mn,[Mn++],54.938,Homogeneous transition metal compounds,Homogeneous transition metal compounds,
muscular dystrophy,9992,PMGT1_HUMAN,Manganese,HMDB0001333,Mn,[Mn++],54.938,Homogeneous transition metal compounds,Homogeneous transition metal compounds,
muscular dystrophy,9963,POMT2_HUMAN,Manganese,HMDB0001333,Mn,[Mn++],54.938,Homogeneous transition metal compounds,Homogeneous transition metal compounds,
muscular dystrophy,15595,ACES_HUMAN,Mefloquine,HMDB0014502,C17H16F6N2O,OC(C1CCCCN1)C1=CC(=NC2=C1C=CC=C2C(F)(F)F)C(F)(F)F,378.3122,4-quinolinemethanols,Quinolines and derivatives,4-quinolinemethanols
muscular dystrophy,17341,CHLE_HUMAN,Mefloquine,HMDB0014502,C17H16F6N2O,OC(C1CCCCN1)C1=CC(=NC2=C1C=CC=C2C(F)(F)F)C(F)(F)F,378.3122,4-quinolinemethanols,Quinolines and derivatives,4-quinolinemethanols
muscular dystrophy,17341,CHLE_HUMAN,Mefloquine,HMDB0014502,C17H16F6N2O,OC(C1CCCCN1)C1=CC(=NC2=C1C=CC=C2C(F)(F)F)C(F)(F)F,378.3122,4-quinolinemethanols,Quinolines and derivatives,4-quinolinemethanols
muscular dystrophy,17341,CHLE_HUMAN,Mefloquine,HMDB0014502,C17H16F6N2O,OC(C1CCCCN1)C1=CC(=NC2=C1C=CC=C2C(F)(F)F)C(F)(F)F,378.3122,4-quinolinemethanols,Quinolines and derivatives,4-quinolinemethanols
muscular dystrophy,15595,ACES_HUMAN,Mefloquine,HMDB0014502,C17H16F6N2O,OC(C1CCCCN1)C1=CC(=NC2=C1C=CC=C2C(F)(F)F)C(F)(F)F,378.3122,4-quinolinemethanols,Quinolines and derivatives,4-quinolinemethanols
muscular dystrophy,15595,ACES_HUMAN,Mefloquine,HMDB0014502,C17H16F6N2O,OC(C1CCCCN1)C1=CC(=NC2=C1C=CC=C2C(F)(F)F)C(F)(F)F,378.3122,4-quinolinemethanols,Quinolines and derivatives,4-quinolinemethanols
muscular dystrophy,15595,ACES_HUMAN,Minaprine,HMDB0014943,C17H22N4O,CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1,298.3828,Phenylpyridazines,Diazines,Pyridazines and derivatives
muscular dystrophy,15595,ACES_HUMAN,Minaprine,HMDB0014943,C17H22N4O,CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1,298.3828,Phenylpyridazines,Diazines,Pyridazines and derivatives
muscular dystrophy,15595,ACES_HUMAN,Minaprine,HMDB0014943,C17H22N4O,CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1,298.3828,Phenylpyridazines,Diazines,Pyridazines and derivatives
muscular dystrophy,17341,CHLE_HUMAN,Mivacurium,HMDB0015357,C58H80N2O14,COC1=CC(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CCC=CCCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC,1029.2608,Benzylisoquinolines,Isoquinolines and derivatives,Benzylisoquinolines
muscular dystrophy,17341,CHLE_HUMAN,Mivacurium,HMDB0015357,C58H80N2O14,COC1=CC(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CCC=CCCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC,1029.2608,Benzylisoquinolines,Isoquinolines and derivatives,Benzylisoquinolines
muscular dystrophy,17341,CHLE_HUMAN,Mivacurium,HMDB0015357,C58H80N2O14,COC1=CC(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CCC=CCCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC,1029.2608,Benzylisoquinolines,Isoquinolines and derivatives,Benzylisoquinolines
muscular dystrophy,17341,CHLE_HUMAN,Myristic acid,HMDB0000806,C14H28O2,CCCCCCCCCCCCCC(O)=O,228.3709,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Myristic acid,HMDB0000806,C14H28O2,CCCCCCCCCCCCCC(O)=O,228.3709,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Myristic acid,HMDB0000806,C14H28O2,CCCCCCCCCCCCCC(O)=O,228.3709,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,9992,PMGT1_HUMAN,N-Acetyl-D-glucosamine,HMDB0000215,C8H15NO6,CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O,221.2078,Acylaminosugars,Organooxygen compounds,Carbohydrates and carbohydrate conjugates
muscular dystrophy,17341,CHLE_HUMAN,Neostigmine,HMDB0015472,C12H19N2O2,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C,223.2915,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,15595,ACES_HUMAN,Neostigmine,HMDB0015472,C12H19N2O2,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C,223.2915,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,15595,ACES_HUMAN,Neostigmine,HMDB0015472,C12H19N2O2,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C,223.2915,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,15595,ACES_HUMAN,Neostigmine,HMDB0015472,C12H19N2O2,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C,223.2915,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,17341,CHLE_HUMAN,Neostigmine,HMDB0015472,C12H19N2O2,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C,223.2915,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,17341,CHLE_HUMAN,Neostigmine,HMDB0015472,C12H19N2O2,CN(C)C(=O)OC1=CC(=CC=C1)[N+](C)(C)C,223.2915,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,17341,CHLE_HUMAN,Nizatidine,HMDB0014723,C12H21N5O2S2,CNC(NCCSCC1=CSC(CN(C)C)=N1)=C/[N+]([O-])=O,331.457,"2,4-disubstituted thiazoles",Azoles,Thiazoles
muscular dystrophy,17341,CHLE_HUMAN,Nizatidine,HMDB0014723,C12H21N5O2S2,CNC(NCCSCC1=CSC(CN(C)C)=N1)=C/[N+]([O-])=O,331.457,"2,4-disubstituted thiazoles",Azoles,Thiazoles
muscular dystrophy,17341,CHLE_HUMAN,Nizatidine,HMDB0014723,C12H21N5O2S2,CNC(NCCSCC1=CSC(CN(C)C)=N1)=C/[N+]([O-])=O,331.457,"2,4-disubstituted thiazoles",Azoles,Thiazoles
muscular dystrophy,17341,CHLE_HUMAN,Oxybuprocaine,HMDB0015029,C17H28N2O3,CCCCOC1=C(N)C=CC(=C1)C(=O)OCCN(CC)CC,308.4158,Benzoic acid esters,Benzene and substituted derivatives,Benzoic acids and derivatives
muscular dystrophy,17341,CHLE_HUMAN,Oxybuprocaine,HMDB0015029,C17H28N2O3,CCCCOC1=C(N)C=CC(=C1)C(=O)OCCN(CC)CC,308.4158,Benzoic acid esters,Benzene and substituted derivatives,Benzoic acids and derivatives
muscular dystrophy,17341,CHLE_HUMAN,Oxybuprocaine,HMDB0015029,C17H28N2O3,CCCCOC1=C(N)C=CC(=C1)C(=O)OCCN(CC)CC,308.4158,Benzoic acid esters,Benzene and substituted derivatives,Benzoic acids and derivatives
muscular dystrophy,17341,CHLE_HUMAN,Palmitic acid,HMDB0000220,C16H32O2,CCCCCCCCCCCCCCCC(O)=O,256.4241,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Palmitic acid,HMDB0000220,C16H32O2,CCCCCCCCCCCCCCCC(O)=O,256.4241,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Palmitic acid,HMDB0000220,C16H32O2,CCCCCCCCCCCCCCCC(O)=O,256.4241,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Pancuronium,HMDB0015430,C35H60N2O4,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1,572.8619,Steroid esters,Steroids and steroid derivatives,Steroid esters
muscular dystrophy,17341,CHLE_HUMAN,Pancuronium,HMDB0015430,C35H60N2O4,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1,572.8619,Steroid esters,Steroids and steroid derivatives,Steroid esters
muscular dystrophy,17341,CHLE_HUMAN,Pancuronium,HMDB0015430,C35H60N2O4,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)[N+]1(C)CCCCC1)[N+]1(C)CCCCC1,572.8619,Steroid esters,Steroids and steroid derivatives,Steroid esters
muscular dystrophy,17341,CHLE_HUMAN,Pentadecanoic acid,HMDB0000826,C15H30O2,CCCCCCCCCCCCCCC(O)=O,242.3975,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Pentadecanoic acid,HMDB0000826,C15H30O2,CCCCCCCCCCCCCCC(O)=O,242.3975,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Pentadecanoic acid,HMDB0000826,C15H30O2,CCCCCCCCCCCCCCC(O)=O,242.3975,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Pentagastrin,HMDB0014329,C37H49N7O9S,CSCC[C@H](NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)CCNC(=O)OCC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,767.891,Hybrid peptides,Peptidomimetics,Hybrid peptides
muscular dystrophy,17341,CHLE_HUMAN,Pentagastrin,HMDB0014329,C37H49N7O9S,CSCC[C@H](NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)CCNC(=O)OCC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,767.891,Hybrid peptides,Peptidomimetics,Hybrid peptides
muscular dystrophy,17341,CHLE_HUMAN,Pentagastrin,HMDB0014329,C37H49N7O9S,CSCC[C@H](NC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)CCNC(=O)OCC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(N)=O,767.891,Hybrid peptides,Peptidomimetics,Hybrid peptides
muscular dystrophy,17341,CHLE_HUMAN,Perindopril,HMDB0014928,C19H32N2O5,[H][C@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O,368.4678,Dipeptides,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues"
muscular dystrophy,17341,CHLE_HUMAN,Perindopril,HMDB0014928,C19H32N2O5,[H][C@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O,368.4678,Dipeptides,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues"
muscular dystrophy,17341,CHLE_HUMAN,Perindopril,HMDB0014928,C19H32N2O5,[H][C@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O,368.4678,Dipeptides,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues"
muscular dystrophy,16312,TRI32_HUMAN,Phosphate,HMDB0001429,H3O4P,OP(O)(O)=O,97.9952,Non-metal phosphates,Non-metal oxoanionic compounds,Non-metal phosphates
muscular dystrophy,17836,GMPPB_HUMAN,Phosphate,HMDB0001429,H3O4P,OP(O)(O)=O,97.9952,Non-metal phosphates,Non-metal oxoanionic compounds,Non-metal phosphates
muscular dystrophy,15595,ACES_HUMAN,Physostigmine,HMDB0015116,C15H21N3O2,[H][C@]12N(C)CC[C@@]1(C)C1=C(C=CC(OC(=O)NC)=C1)N2C,275.3461,Pyrroloindoles,Indoles and derivatives,Pyrroloindoles
muscular dystrophy,15595,ACES_HUMAN,Physostigmine,HMDB0015116,C15H21N3O2,[H][C@]12N(C)CC[C@@]1(C)C1=C(C=CC(OC(=O)NC)=C1)N2C,275.3461,Pyrroloindoles,Indoles and derivatives,Pyrroloindoles
muscular dystrophy,15595,ACES_HUMAN,Physostigmine,HMDB0015116,C15H21N3O2,[H][C@]12N(C)CC[C@@]1(C)C1=C(C=CC(OC(=O)NC)=C1)N2C,275.3461,Pyrroloindoles,Indoles and derivatives,Pyrroloindoles
muscular dystrophy,17341,CHLE_HUMAN,Pipecuronium,HMDB0015431,C35H62N4O4,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1,602.8912,Steroid esters,Steroids and steroid derivatives,Steroid esters
muscular dystrophy,17341,CHLE_HUMAN,Pipecuronium,HMDB0015431,C35H62N4O4,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1,602.8912,Steroid esters,Steroids and steroid derivatives,Steroid esters
muscular dystrophy,17341,CHLE_HUMAN,Pipecuronium,HMDB0015431,C35H62N4O4,[H][C@@]12C[C@@H]([C@H](OC(C)=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])C[C@H](OC(C)=O)[C@H](C[C@]12C)N1CC[N+](C)(C)CC1)N1CC[N+](C)(C)CC1,602.8912,Steroid esters,Steroids and steroid derivatives,Steroid esters
muscular dystrophy,17341,CHLE_HUMAN,Pralidoxime,HMDB0014871,C7H9N2O,C[N+]1=C(C=NO)C=CC=C1,137.1592,N-methylpyridinium compounds,Pyridines and derivatives,Methylpyridines
muscular dystrophy,15595,ACES_HUMAN,Pralidoxime,HMDB0014871,C7H9N2O,C[N+]1=C(C=NO)C=CC=C1,137.1592,N-methylpyridinium compounds,Pyridines and derivatives,Methylpyridines
muscular dystrophy,17341,CHLE_HUMAN,Pralidoxime,HMDB0014871,C7H9N2O,C[N+]1=C(C=NO)C=CC=C1,137.1592,N-methylpyridinium compounds,Pyridines and derivatives,Methylpyridines
muscular dystrophy,15595,ACES_HUMAN,Pralidoxime,HMDB0014871,C7H9N2O,C[N+]1=C(C=NO)C=CC=C1,137.1592,N-methylpyridinium compounds,Pyridines and derivatives,Methylpyridines
muscular dystrophy,15595,ACES_HUMAN,Pralidoxime,HMDB0014871,C7H9N2O,C[N+]1=C(C=NO)C=CC=C1,137.1592,N-methylpyridinium compounds,Pyridines and derivatives,Methylpyridines
muscular dystrophy,17341,CHLE_HUMAN,Pralidoxime,HMDB0014871,C7H9N2O,C[N+]1=C(C=NO)C=CC=C1,137.1592,N-methylpyridinium compounds,Pyridines and derivatives,Methylpyridines
muscular dystrophy,17341,CHLE_HUMAN,Procainamide,HMDB0015169,C13H21N3O,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,235.3253,Aminobenzamides,Benzene and substituted derivatives,Benzoic acids and derivatives
muscular dystrophy,17341,CHLE_HUMAN,Procainamide,HMDB0015169,C13H21N3O,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,235.3253,Aminobenzamides,Benzene and substituted derivatives,Benzoic acids and derivatives
muscular dystrophy,17341,CHLE_HUMAN,Procainamide,HMDB0015169,C13H21N3O,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,235.3253,Aminobenzamides,Benzene and substituted derivatives,Benzoic acids and derivatives
muscular dystrophy,17341,CHLE_HUMAN,Procaine,HMDB0014859,C13H20N2O2,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1,236.3101,Benzoic acid esters,Benzene and substituted derivatives,Benzoic acids and derivatives
muscular dystrophy,17341,CHLE_HUMAN,Procaine,HMDB0014859,C13H20N2O2,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1,236.3101,Benzoic acid esters,Benzene and substituted derivatives,Benzoic acids and derivatives
muscular dystrophy,17341,CHLE_HUMAN,Procaine,HMDB0014859,C13H20N2O2,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1,236.3101,Benzoic acid esters,Benzene and substituted derivatives,Benzoic acids and derivatives
muscular dystrophy,17341,CHLE_HUMAN,Pyridostigmine,HMDB0014685,C9H13N2O2,CN(C)C(=O)OC1=C[N+](C)=CC=C1,181.2117,N-methylpyridinium compounds,Pyridines and derivatives,Methylpyridines
muscular dystrophy,15595,ACES_HUMAN,Pyridostigmine,HMDB0014685,C9H13N2O2,CN(C)C(=O)OC1=C[N+](C)=CC=C1,181.2117,N-methylpyridinium compounds,Pyridines and derivatives,Methylpyridines
muscular dystrophy,15595,ACES_HUMAN,Pyridostigmine,HMDB0014685,C9H13N2O2,CN(C)C(=O)OC1=C[N+](C)=CC=C1,181.2117,N-methylpyridinium compounds,Pyridines and derivatives,Methylpyridines
muscular dystrophy,17341,CHLE_HUMAN,Pyridostigmine,HMDB0014685,C9H13N2O2,CN(C)C(=O)OC1=C[N+](C)=CC=C1,181.2117,N-methylpyridinium compounds,Pyridines and derivatives,Methylpyridines
muscular dystrophy,17341,CHLE_HUMAN,Pyridostigmine,HMDB0014685,C9H13N2O2,CN(C)C(=O)OC1=C[N+](C)=CC=C1,181.2117,N-methylpyridinium compounds,Pyridines and derivatives,Methylpyridines
muscular dystrophy,15595,ACES_HUMAN,Pyridostigmine,HMDB0014685,C9H13N2O2,CN(C)C(=O)OC1=C[N+](C)=CC=C1,181.2117,N-methylpyridinium compounds,Pyridines and derivatives,Methylpyridines
muscular dystrophy,17836,GMPPB_HUMAN,Pyrophosphate,HMDB0000250,H4O7P2,OP(O)(=O)OP(O)(O)=O,177.9751,Non-metal pyrophosphates,Non-metal oxoanionic compounds,Non-metal pyrophosphates
muscular dystrophy,16312,TRI32_HUMAN,Pyrophosphate,HMDB0000250,H4O7P2,OP(O)(=O)OP(O)(O)=O,177.9751,Non-metal pyrophosphates,Non-metal oxoanionic compounds,Non-metal pyrophosphates
muscular dystrophy,17341,CHLE_HUMAN,R-95913,HMDB0013930,C18H18FNO2S,OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1,331.404,Thienopyridines,Thienopyridines,
muscular dystrophy,17341,CHLE_HUMAN,R-95913,HMDB0013930,C18H18FNO2S,OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1,331.404,Thienopyridines,Thienopyridines,
muscular dystrophy,17341,CHLE_HUMAN,R-95913,HMDB0013930,C18H18FNO2S,OC1=CC2=C(CCN(C2)C(C(=O)C2CC2)C2=CC=CC=C2F)S1,331.404,Thienopyridines,Thienopyridines,
muscular dystrophy,17341,CHLE_HUMAN,Ramipril,HMDB0014324,C23H32N2O5,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,416.5106,Dipeptides,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues"
muscular dystrophy,17341,CHLE_HUMAN,Ramipril,HMDB0014324,C23H32N2O5,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,416.5106,Dipeptides,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues"
muscular dystrophy,17341,CHLE_HUMAN,Ramipril,HMDB0014324,C23H32N2O5,[H][C@@]12CCC[C@]1([H])N([C@@H](C2)C(O)=O)C(=O)[C@H](C)N[C@@H](CCC1=CC=CC=C1)C(=O)OCC,416.5106,Dipeptides,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues"
muscular dystrophy,5486,ISPD_HUMAN,ribose-5-phosphate,HMDB0257215,C5H11O8P,OC(COP(O)(O)=O)C(O)C(O)C=O,230.109,Pentose phosphates,Organooxygen compounds,Carbohydrates and carbohydrate conjugates
muscular dystrophy,17341,CHLE_HUMAN,Rivastigmine,HMDB0015124,C14H22N2O2,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,250.3367,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,15595,ACES_HUMAN,Rivastigmine,HMDB0015124,C14H22N2O2,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,250.3367,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,15595,ACES_HUMAN,Rivastigmine,HMDB0015124,C14H22N2O2,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,250.3367,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,15595,ACES_HUMAN,Rivastigmine,HMDB0015124,C14H22N2O2,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,250.3367,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,17341,CHLE_HUMAN,Rivastigmine,HMDB0015124,C14H22N2O2,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,250.3367,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,17341,CHLE_HUMAN,Rivastigmine,HMDB0015124,C14H22N2O2,CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C,250.3367,Phenoxy compounds,Benzene and substituted derivatives,Phenoxy compounds
muscular dystrophy,8327,SELN_HUMAN,ryanodine,HMDB0257371,C25H35NO9,CC(C)C1(O)C(OC(=O)C2=CC=CN2)C2(O)C3(C)CC4(O)OC5(C(O)C(C)CCC35O)C2(O)C14C,493.553,Diterpenoids,Prenol lipids,Diterpenoids
muscular dystrophy,8327,SELN_HUMAN,ryanodine,HMDB0257371,C25H35NO9,CC(C)C1(O)C(OC(=O)C2=CC=CN2)C2(O)C3(C)CC4(O)OC5(C(O)C(C)CCC35O)C2(O)C14C,493.553,Diterpenoids,Prenol lipids,Diterpenoids
muscular dystrophy,8327,SELN_HUMAN,ryanodine,HMDB0257371,C25H35NO9,CC(C)C1(O)C(OC(=O)C2=CC=CN2)C2(O)C3(C)CC4(O)OC5(C(O)C(C)CCC35O)C2(O)C14C,493.553,Diterpenoids,Prenol lipids,Diterpenoids
muscular dystrophy,8327,SELN_HUMAN,Selenium,HMDB0001349,Se,[Se++],78.96,Homogeneous other non-metal compounds,Homogeneous other non-metal compounds,
muscular dystrophy,8327,SELN_HUMAN,Selenium,HMDB0001349,Se,[Se++],78.96,Homogeneous other non-metal compounds,Homogeneous other non-metal compounds,
muscular dystrophy,8327,SELN_HUMAN,Selenium,HMDB0001349,Se,[Se++],78.96,Homogeneous other non-metal compounds,Homogeneous other non-metal compounds,
muscular dystrophy,8327,SELN_HUMAN,Selenocysteine,HMDB0003288,C3H7NO2Se,N[C@@H](C[SeH])C(O)=O,168.05,L-alpha-amino acids,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues"
muscular dystrophy,8327,SELN_HUMAN,Selenocysteine,HMDB0003288,C3H7NO2Se,N[C@@H](C[SeH])C(O)=O,168.05,L-alpha-amino acids,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues"
muscular dystrophy,8327,SELN_HUMAN,Selenocysteine,HMDB0003288,C3H7NO2Se,N[C@@H](C[SeH])C(O)=O,168.05,L-alpha-amino acids,Carboxylic acids and derivatives,"Amino acids, peptides, and analogues"
muscular dystrophy,17341,CHLE_HUMAN,Stearic acid,HMDB0000827,C18H36O2,CCCCCCCCCCCCCCCCCC(O)=O,284.4772,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Stearic acid,HMDB0000827,C18H36O2,CCCCCCCCCCCCCCCCCC(O)=O,284.4772,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Stearic acid,HMDB0000827,C18H36O2,CCCCCCCCCCCCCCCCCC(O)=O,284.4772,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Substance P,HMDB0001897,C63H98N18O13S,CSCC[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)CNC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,1347.63,Tocopherols,Prenol lipids,Quinone and hydroquinone lipids
muscular dystrophy,17341,CHLE_HUMAN,Substance P,HMDB0001897,C63H98N18O13S,CSCC[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)CNC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,1347.63,Tocopherols,Prenol lipids,Quinone and hydroquinone lipids
muscular dystrophy,17341,CHLE_HUMAN,Substance P,HMDB0001897,C63H98N18O13S,CSCC[C@H](NC(=O)[C@@H](CC(C)C)NC(=O)CNC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCNC(N)=N)C(N)=O,1347.63,Tocopherols,Prenol lipids,Quinone and hydroquinone lipids
muscular dystrophy,17341,CHLE_HUMAN,Succinylcholine,HMDB0014347,C14H30N2O4,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,290.399,Acyl cholines,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,17341,CHLE_HUMAN,Succinylcholine,HMDB0014347,C14H30N2O4,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,290.399,Acyl cholines,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,17341,CHLE_HUMAN,Succinylcholine,HMDB0014347,C14H30N2O4,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C,290.399,Acyl cholines,Organonitrogen compounds,Quaternary ammonium salts
muscular dystrophy,17341,CHLE_HUMAN,Sulpiride,HMDB0014535,C15H23N3O4S,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,341.426,Benzenesulfonamides,Benzene and substituted derivatives,Benzenesulfonamides
muscular dystrophy,17341,CHLE_HUMAN,Sulpiride,HMDB0014535,C15H23N3O4S,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,341.426,Benzenesulfonamides,Benzene and substituted derivatives,Benzenesulfonamides
muscular dystrophy,17341,CHLE_HUMAN,Sulpiride,HMDB0014535,C15H23N3O4S,CCN1CCCC1CNC(=O)C1=C(OC)C=CC(=C1)S(N)(=O)=O,341.426,Benzenesulfonamides,Benzene and substituted derivatives,Benzenesulfonamides
muscular dystrophy,17341,CHLE_HUMAN,Tacrine,HMDB0014526,C13H14N2,NC1=C2CCCCC2=NC2=CC=CC=C12,198.2637,Acridines,Quinolines and derivatives,Benzoquinolines
muscular dystrophy,15595,ACES_HUMAN,Tacrine,HMDB0014526,C13H14N2,NC1=C2CCCCC2=NC2=CC=CC=C12,198.2637,Acridines,Quinolines and derivatives,Benzoquinolines
muscular dystrophy,15595,ACES_HUMAN,Tacrine,HMDB0014526,C13H14N2,NC1=C2CCCCC2=NC2=CC=CC=C12,198.2637,Acridines,Quinolines and derivatives,Benzoquinolines
muscular dystrophy,15595,ACES_HUMAN,Tacrine,HMDB0014526,C13H14N2,NC1=C2CCCCC2=NC2=CC=CC=C12,198.2637,Acridines,Quinolines and derivatives,Benzoquinolines
muscular dystrophy,17341,CHLE_HUMAN,Tacrine,HMDB0014526,C13H14N2,NC1=C2CCCCC2=NC2=CC=CC=C12,198.2637,Acridines,Quinolines and derivatives,Benzoquinolines
muscular dystrophy,17341,CHLE_HUMAN,Tacrine,HMDB0014526,C13H14N2,NC1=C2CCCCC2=NC2=CC=CC=C12,198.2637,Acridines,Quinolines and derivatives,Benzoquinolines
muscular dystrophy,17341,CHLE_HUMAN,Terbutaline,HMDB0015009,C12H19NO3,CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1,225.2842,Resorcinols,Phenols,Benzenediols
muscular dystrophy,17341,CHLE_HUMAN,Terbutaline,HMDB0015009,C12H19NO3,CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1,225.2842,Resorcinols,Phenols,Benzenediols
muscular dystrophy,17341,CHLE_HUMAN,Terbutaline,HMDB0015009,C12H19NO3,CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1,225.2842,Resorcinols,Phenols,Benzenediols
muscular dystrophy,17341,CHLE_HUMAN,Tridecanoic acid,HMDB0000910,C13H26O2,CCCCCCCCCCCCC(O)=O,214.3443,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Tridecanoic acid,HMDB0000910,C13H26O2,CCCCCCCCCCCCC(O)=O,214.3443,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Tridecanoic acid,HMDB0000910,C13H26O2,CCCCCCCCCCCCC(O)=O,214.3443,Long-chain fatty acids,Fatty Acyls,Fatty acids and conjugates
muscular dystrophy,17341,CHLE_HUMAN,Trimethaphan,HMDB0015248,C22H25N2OS,O=C1N(CC2=CC=CC=C2)C2C[S+]3CCCC3C2N1CC1=CC=CC=C1,365.512,Thienoimidazolidines,Thienoimidazolidines,
muscular dystrophy,17341,CHLE_HUMAN,Trimethaphan,HMDB0015248,C22H25N2OS,O=C1N(CC2=CC=CC=C2)C2C[S+]3CCCC3C2N1CC1=CC=CC=C1,365.512,Thienoimidazolidines,Thienoimidazolidines,
muscular dystrophy,17341,CHLE_HUMAN,Trimethaphan,HMDB0015248,C22H25N2OS,O=C1N(CC2=CC=CC=C2)C2C[S+]3CCCC3C2N1CC1=CC=CC=C1,365.512,Thienoimidazolidines,Thienoimidazolidines,
muscular dystrophy,15595,ACES_HUMAN,Tubocurarine,HMDB0015330,C37H41N2O6,[H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CCN1C)C2=C6)=C(O)C=C5)=CC(OC)=C4O)C=C3,609.7312,Diarylethers,Organooxygen compounds,Ethers
muscular dystrophy,15595,ACES_HUMAN,Tubocurarine,HMDB0015330,C37H41N2O6,[H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CCN1C)C2=C6)=C(O)C=C5)=CC(OC)=C4O)C=C3,609.7312,Diarylethers,Organooxygen compounds,Ethers
muscular dystrophy,15595,ACES_HUMAN,Tubocurarine,HMDB0015330,C37H41N2O6,[H][C@@]12CC3=CC=C(OC4=C5C(CC[N+](C)(C)[C@]5([H])CC5=CC(OC6=C(OC)C=C(CCN1C)C2=C6)=C(O)C=C5)=CC(OC)=C4O)C=C3,609.7312,Diarylethers,Organooxygen compounds,Ethers
muscular dystrophy,9992,PMGT1_HUMAN,Uridine 5'-diphosphate,HMDB0000295,C9H14N2O12P2,O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(O)(=O)OP(O)(O)=O)N1C=CC(=O)NC1=O,404.1612,Pyrimidine ribonucleoside diphosphates,Pyrimidine nucleotides,Pyrimidine ribonucleotides
muscular dystrophy,9992,PMGT1_HUMAN,Uridine diphosphate-N-acetylglucosamine,HMDB0000290,C17H27N3O17P2,CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O,607.3537,Pyrimidine nucleotide sugars,Pyrimidine nucleotides,Pyrimidine nucleotide sugars
muscular dystrophy,17341,CHLE_HUMAN,Water,HMDB0002111,H2O,O,18.0153,Homogeneous other non-metal compounds,Homogeneous other non-metal compounds,
muscular dystrophy,15595,ACES_HUMAN,Water,HMDB0002111,H2O,O,18.0153,Homogeneous other non-metal compounds,Homogeneous other non-metal compounds,
muscular dystrophy,15595,ACES_HUMAN,Water,HMDB0002111,H2O,O,18.0153,Homogeneous other non-metal compounds,Homogeneous other non-metal compounds,
muscular dystrophy,15595,ACES_HUMAN,Water,HMDB0002111,H2O,O,18.0153,Homogeneous other non-metal compounds,Homogeneous other non-metal compounds,
muscular dystrophy,17341,CHLE_HUMAN,Water,HMDB0002111,H2O,O,18.0153,Homogeneous other non-metal compounds,Homogeneous other non-metal compounds,
muscular dystrophy,17341,CHLE_HUMAN,Water,HMDB0002111,H2O,O,18.0153,Homogeneous other non-metal compounds,Homogeneous other non-metal compounds,
